{"id":63067,"date":"2026-05-06T19:02:30","date_gmt":"2026-05-06T17:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/"},"modified":"2026-05-06T19:02:30","modified_gmt":"2026-05-06T17:02:30","slug":"anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/","title":{"rendered":"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Facility strengthens balance sheet and provides additional financial flexibility to support execution of contracted project portfolio<\/i><\/p>\n<p>BURLINGTON, ONTARIO&#8211;(BUSINESS WIRE)&#8211;Anaergia Inc. (\u201cAnaergia\u201d, the \u201cCompany\u201d, \u201cus\u201d, or \u201cour\u201d) (TSX: ANRG) (OTCQX: ANRGF), a global provider of integrated waste to-value solutions today announced that it has entered into a credit agreement (the \u201cCredit Agreement\u201d) with National Bank of Canada (the \u201cBank\u201d), as lender, for a revolving credit facility in the maximum principal amount of $20,000,000 (the \u201cCredit Facility\u201d), with an option to increase the maximum principal amount by up to $10,000,000. All amounts are in Canadian dollars unless otherwise stated.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/5\/Anaergia_Logo_2021_w_Tag.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/5\/Anaergia_Logo_2021_w_Tag.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/21\/Anaergia_Logo_2021_w_Tag.jpg\"><\/a><\/p>\n<p>\nThe credit facility provides Anaergia with enhanced liquidity and financial flexibility to support the execution of its existing contracted backlog. Proceeds will be used for general corporate purposes, in accordance with the terms of the Credit Agreement.<\/p>\n<p>\n&#8220;This agreement with National Bank of Canada reflects growing institutional confidence in Anaergia\u2019s business model, project execution capabilities, and financial discipline,\u201d said Assaf Onn, CEO of Anaergia. \u201cThe facility meaningfully strengthens our balance sheet flexibility as we deliver complex infrastructure projects for customers across multiple geographies.\u201d<\/p>\n<p>\nCapitalized terms used herein and not otherwise defined have the meanings ascribed to them in the Credit Agreement.<\/p>\n<p>\n<b>Key Terms of the Credit Facility<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nRevolving credit facility with a maximum principal amount of $20 million<\/li>\n<li>\nOption to increase commitments to up to $30 million, at the Bank\u2019s sole discretion and subject to the satisfaction of certain conditions.<\/li>\n<li>\nThe total principal amount outstanding under the Credit Facility shall not exceed the Borrowing Base at any time.<\/li>\n<li>\nThree-year maturity from the effective date of the Credit Agreement<\/li>\n<li>\nBullet repayment at maturity, with the ability to prepay at any time without penalty.<\/li>\n<li>\nThe Credit Facility bears interest at rates determined by reference to the applicable pricing tier based on the Company\u2019s Debt to EBITDA Ratio and are subject to the satisfaction of certain customary conditions precedent.<\/li>\n<li>\nSenior-secured facility subject to standard and customary terms and conditions with respect to fees, representations, warranties and financial covenants.<\/li>\n<\/ul>\n<p>\nThe summary of the key terms of the Credit Facility above is qualified in its entirety by the full text of the Credit Agreement, a copy of which will be available on the Company\u2019s SEDAR+ profile at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54530501&amp;newsitemid=20260506144541&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6ebf19860b71fb83e91d1a83f597a8bd\" rel=\"nofollow\" shape=\"rect\">www.sedarplus.ca<\/a>.<\/p>\n<p>\n<b>About National Bank of Canada<\/b><\/p>\n<p>\nWith $606 billion in assets as at January 31, 2026, the Bank is one of Canada\u2019s six systemically important banks. The Bank has more than 35,000 employees in knowledge-intensive positions and operates three business segments in Canada: Personal and Commercial Banking, Wealth Management and Capital Markets. A fourth segment, U.S. Specialty Finance and International, complements the growth of its domestic operations. Its securities are listed on the Toronto Stock Exchange (TSX: NA).<\/p>\n<p>\nFor further information please see: <b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nbc.ca%2F&amp;esheet=54530501&amp;newsitemid=20260506144541&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.nbc.ca%2F&amp;index=2&amp;md5=8fc9cc751806f1536590523bea5fc029\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.nbc.ca\/<\/a><\/b><\/p>\n<p>\n<b>About Anaergia<\/b><\/p>\n<p>\nAnaergia is a global technology company specializing in renewable natural gas and organic\u2011waste\u2011to\u2011value solutions. The Company delivers integrated design, equipment, construction, and operational solutions that convert organic waste into renewable energy, fertilizer, and water. With hundreds of patents and a track record of delivering complex projects worldwide, Anaergia supports customers in reducing greenhouse\u2011gas emissions while improving the economics of waste and wastewater infrastructure.<\/p>\n<p>\nFor further information please see: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.anaergia.com%2F&amp;esheet=54530501&amp;newsitemid=20260506144541&amp;lan=en-US&amp;anchor=www.anaergia.com&amp;index=3&amp;md5=78713760829effadc9ecf20d19272262\" rel=\"nofollow\" shape=\"rect\">www.anaergia.com<\/a><\/p>\n<p>\n<b>Forward-Looking Statements<\/b><\/p>\n<p>\n<i>This press release contains \u201cforward-looking information\u201d within the meaning of applicable securities laws. Forward-looking information may relate to future plans, expectations and intentions, results, levels of activity, performance, goals or achievements, other future events or developments and may include, without limitation, information regarding our financial position, business strategy, growth strategy, budgets, operations, financial results, taxes, plans and objectives. Particularly, information regarding our future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as \u201cmay\u201d, \u201cwill\u201d, \u201cwould\u201d, \u201cshould\u201d, \u201ccould\u201d, \u201cexpects\u201d, \u201cplans\u201d, \u201cintends\u201d, \u201cestimate\u201d, \u201cbelieves\u201d, \u201clikely\u201d, \u201cpotential\u201d, \u201ccontinue\u201d, or \u201cfuture\u201d or the negative or other variations of these words or other comparable words or phrases. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Forward-looking statements in this press release include, among other things, statements relating to the anticipated use of proceeds of the Credit Facility, the satisfaction of conditions precedent to advances under the Credit Facility and any increase in commitments under the Credit Facility. Statements containing forward-looking information are not facts but instead represent management\u2019s expectations, estimates and projections regarding future events or circumstances.<\/i><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nFor media and\/or investor relations please contact: <a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x49;&#82;&#64;&#x41;&#110;&#x61;&#101;r&#x67;&#105;&#x61;&#x2e;c&#x6f;&#109;\" rel=\"nofollow\" shape=\"rect\">&#73;&#x52;&#64;&#x41;&#110;&#x61;e&#x72;g&#x69;a&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Facility strengthens balance sheet and provides additional financial flexibility to support execution of contracted project portfolio BURLINGTON, ONTARIO&#8211;(BUSINESS WIRE)&#8211;Anaergia Inc. (\u201cAnaergia\u201d, the \u201cCompany\u201d, \u201cus\u201d, or \u201cour\u201d) (TSX: ANRG) (OTCQX: ANRGF), a global provider of integrated waste to-value solutions today announced that it has entered into a credit agreement (the \u201cCredit Agreement\u201d) with National Bank of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63067","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Facility strengthens balance sheet and provides additional financial flexibility to support execution of contracted project portfolio BURLINGTON, ONTARIO&#8211;(BUSINESS WIRE)&#8211;Anaergia Inc. (\u201cAnaergia\u201d, the \u201cCompany\u201d, \u201cus\u201d, or \u201cour\u201d) (TSX: ANRG) (OTCQX: ANRGF), a global provider of integrated waste to-value solutions today announced that it has entered into a credit agreement (the \u201cCredit Agreement\u201d) with National Bank of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-06T17:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada\",\"datePublished\":\"2026-05-06T17:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/\"},\"wordCount\":769,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260506144541\\\/en\\\/1142102\\\/22\\\/Anaergia_Logo_2021_w_Tag.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/\",\"name\":\"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260506144541\\\/en\\\/1142102\\\/22\\\/Anaergia_Logo_2021_w_Tag.jpg\",\"datePublished\":\"2026-05-06T17:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260506144541\\\/en\\\/1142102\\\/22\\\/Anaergia_Logo_2021_w_Tag.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260506144541\\\/en\\\/1142102\\\/22\\\/Anaergia_Logo_2021_w_Tag.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/","og_locale":"en_US","og_type":"article","og_title":"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada - Pharma Trend","og_description":"Facility strengthens balance sheet and provides additional financial flexibility to support execution of contracted project portfolio BURLINGTON, ONTARIO&#8211;(BUSINESS WIRE)&#8211;Anaergia Inc. (\u201cAnaergia\u201d, the \u201cCompany\u201d, \u201cus\u201d, or \u201cour\u201d) (TSX: ANRG) (OTCQX: ANRGF), a global provider of integrated waste to-value solutions today announced that it has entered into a credit agreement (the \u201cCredit Agreement\u201d) with National Bank of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/","og_site_name":"Pharma Trend","article_published_time":"2026-05-06T17:02:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada","datePublished":"2026-05-06T17:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/"},"wordCount":769,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/","url":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/","name":"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg","datePublished":"2026-05-06T17:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260506144541\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/anaergia-secures-20-million-revolving-credit-facility-with-national-bank-of-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anaergia Secures $20 Million Revolving Credit Facility with National Bank of Canada"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63067"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63067\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}